• Skip to main content
  • Main Menu
  • Navigation for access to support pages
  • Navigation for access to legal pages
Logo Viva Technology
  • FAQ
  • confirmation_numberGet Your Pass
  • Become a Partner
Viva Technology

16-19 June 2027

Paris Expo Porte de Versailles

1 Place de la Porte de Versailles

F-75015 Paris France

More Infoarrow_right_alt

Event organizers

ThemesConference ProgramSpeakersPartners

Exhibitors at VivaTech

Startups at VivaTechInvestors at VivaTech2026 Startup Challenges and Awards

JournalistsMedia PartnersPress Releases

About UsOur CommitmentsPractical Information

©VivaTech 2016-2026 all rights reserved

Site MapSite NoticeB2B Terms & ConditionsData PrivacyStudent Terms & Conditions
Human 2.0? The Fertility Revolution and the Future of Reproduction - [Session VivaTech] - Theme: Health & Longevity
  1. Logo Viva Technology
  2. Sessions
  3. Session detail

Speakers

Photo Anu Bashamboo

Anu Bashamboo

Senior Group Leader, Human Developmental Genetics
Institut Pasteur
Photo Micheline Misrahi-Abadou

Micheline Misrahi-Abadou

Professor of Biochemistry and Molecular Biology
Paris-Saclay Faculty of Medicine, Member of the Academia Europaea and the European Academy of Sciences
Photo Phineas Rueckert

Phineas Rueckert

Journalist
Freelance
Photo Jennifer Sciubba

Jennifer Sciubba

President & CEO
Population Reference Bureau
Photo Kais Zhioua

Kais Zhioua

Co-Founder CEO
Tanit Healthcare Technologies

Health & Longevity

Human 2.0? The Fertility Revolution and the Future of Reproduction

distance

Black Stage

calendar_today
June 18

3:55 PM - 4:35 PM - CET

Advances in reproductive medicine are expanding what is possible. From IVF and embryo screening to emerging gene-editing technologies, prospective parents now face choices that were unimaginable just a generation ago. These innovations promise to prevent inherited diseases and offer hope to millions struggling with infertility. But as technologies evolve beyond treatment toward potential enhancement, new ethical and societal questions emerge. Where should the line be drawn between medical care and genetic selection? Who decides which conditions should be prevented and which traits should remain beyond intervention? And as reproductive technologies become more powerful, how can societies balance parental choice, medical responsibility, and collective values about what it means to shape the next generation?
#
Healthcare & Wellness
Diversity & Inclusion